- Global Pharma News & Resources

Rising incidence of chronic diseases is driving demand for Medical Hyperspectral Imaging (HSI), global sales are expected to grow at a CAGR of 6.3% by 2032 | insightSLICE

The global Medical Hyperspectral Imaging (HSI) market size was estimated to be US$ 275 million in 2021 and is expected grow at a CAGR of 6.3% between 2023 to 2032.

Medical Hyperspectral Imaging (HSI) is a non-invasive, completely patient-specific diagnostic imaging modality. Applications for biological and pharmacological imaging are increasingly using HSI technology.

Ultraviolet (UV) to infrared (IR) spectrum light frequencies and lower-frequency electromagnetic radiation can both be used for hyperspectral analysis. These medical hyperspectral imaging technologies can be used to collect specific information on physiological components, such as the precise shape and structure of organs or their chemical makeup.

Access the sample report:

Global Medical Hyperspectral Imaging (HSI) Market Key Segments:

By Product

  • Hyperspectral Imaging Systems
  • Hyperspectral Imaging Accessories

By Application

  • Medical Diagnosis
  • Tissue and Cell Biology
  • Drug Discovery
  • Others

By Technology

  • Visible Hyperspectral Imaging
  • Near-infrared Hyperspectral Imaging
  • Ultraviolet Hyperspectral Imaging
  • Short-wave Infrared Imaging
  • Mid-wave Infrared Hyperspectral Imaging

By End-use

  • Diagnostic Centres
  • Hospitals
  • Research & Academic Centres
  • Pharmaceutical & Biotechnology Companies

By Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Haemoglobin, water, cells, and other non-homogenous components can scatter and absorb light and electromagnetic waves as they travel through biological tissue. In order to track significant changes as the disease worsens, it is possible to detect this variation in the scattering pattern of light or radiation.

The use of transmitted, fluorescent, or reflected light in this way by HSI equipment has proven to be very beneficial for disease prediction and treatment plans. A new era of non-invasive assessment and surgical assistance has therefore emerged thanks to the use of hyperspectral imaging in healthcare.

The key players of the Global Medical Hyperspectral Imaging (HSI) Market are:

Brandywine, ClydeHSI, Corning Incorporated, Cubert, CytoViva, Inc., Norsk Elektro Optikk A/S, Orbital Sidekick, Photon Inc., Surface Optics Corp., Ximea Diaspective Vision GmbH, Headwall Photonics Inc., Imec, Resonon Inc., Specim Spectral Imaging Ltd., and Inno-Spec GmbH are significant market stakeholders in the global hyperspectral imaging.

Read more about the report inclusions:

Driving factors for the growth of Global Medical Hyperspectral Imaging (HSI) Market

The market for hyperspectral medical imaging is anticipated to be driven by increasing patient and clinician awareness of these techniques. The adoption rates of such technologies will be further boosted by improved safety, the convenience of use, and advancements in medical imaging technology.

However, the development of the global medical hyperspectral imaging market would be hampered by the high investment capital needed for such devices and the demand for high-quality medical infrastructure.

The global market for medical hyperspectral imaging is anticipated to grow significantly over the course of the forecasted period. The rising applications of HSI in the healthcare sector for diagnostics, image-guided procedures, and other therapies, combined with technological advancements, are some factors that could act as drivers for this market.

In addition, the rise in cancer prevalence has raised the demand for hyperspectral imaging equipment. Additionally, the expanded market may benefit from an improved understanding of disease early detection.

Uses of hyperspectral imaging devices in the medical sector:

Hyperspectral imaging techniques can offer a thorough understanding of complex medical products, including their efficacy in real-time. These results are visible with offline lab equipment as well as a variety of other tools that can meet the analytical measurement requirements.

The process of developing new medicines is increasingly relying on hyperspectral imaging. and thus, hyperspectral imaging will soon be a crucial component of standard operating production for drug production.

Medical hyperspectral imaging has shown to be useful in detecting malignant cells and allowing doctors to track the development of cancer in real-time. The ability of tumors to respond to specific chemotherapy or radiation treatments is also observable by doctors. These characteristics have contributed to the effective creation of specific and customized therapies for cervix, GI tract, and mouth cancers.

The global hyperspectral imaging market is also anticipated to expand as a result of the numerous benefits of hyperspectral imaging in the pharmaceutical industry. Compared to other optical imaging techniques, hyperspectral imaging probes deeper tissue layers.

It is consequently regarded as both next-generation imaging and the clinical research of the future. Hyperspectral imaging equipment can be used for medical applications that are expanding in the fields of disease pathogenesis and real-time evaluation of tissue and organ damage.

Medical hyperspectral imaging equipment is being used more frequently in both industrial and animal studies. Long-term expansion of medical hyperspectral imaging devices is also projected to benefit from this.

Related reports:

Global Esoteric Testing Market:

Global Dementia Care Products Market:

Regional performance of Medical Hyperspectral Imaging (HSI) Market

The demand for medical hyperspectral imaging was dominated by North America in 2020 and is anticipated to continue to do so throughout the forecast period.

This sector will grow as a result of developed healthcare systems in the United States and Canada, increasing funding and research, potential uses of hyperspectral imaging in the industrial sector, and innovations in equipment and software for image analysis and processing.

Additionally, it is anticipated that the market for medical hyperspectral imaging in this region would be driven by improvements in healthcare infrastructure and increased consumer demand for precise surgical procedures throughout the forecasted decade. The rest of the world is anticipated to enable moderate growth for the medical hyperspectral imaging devices market.

Hindering factors for growth of Medical Hyperspectral Imaging (HSI) Market

However, a high risk of technical failure and a lack of healthcare infrastructure to enable medical hyperspectral imaging could make it more challenging for the market to expand as expected. It takes skilled technicians to operate these devices since inexperienced technicians may cause image scanning difficulties and poor detection results.

These issues could affect the clinical output and cost-effectiveness of hyperspectral imaging, which would restrain the market’s expansion in the next few years for medical hyperspectral imaging.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 09-Nov-2022